| scholarly article | Q13442814 |
| P2093 | author name string | A F Castro | |
| C Wang | |||
| D M Wilkes | |||
| G A Altenberg | |||
| P2860 | cites work | Expression and functional properties of the second predicted nucleotide binding fold of the cystic fibrosis transmembrane conductance regulator fused to glutathione-S-transferase. | Q54613850 |
| Factor Xa cleavage of fusion proteins. Elimination of non-specific cleavage by reversible acylation. | Q54714779 | ||
| Recombinant synthesis, purification, and nucleotide binding characteristics of the first nucleotide binding domain of the cystic fibrosis gene product | Q67895667 | ||
| A method for the determination of inorganic phosphate in the presence of labile organic phosphate and high concentrations of protein: application to lens ATPases | Q69825502 | ||
| Recombinant N-terminal nucleotide-binding domain from mouse P-glycoprotein. Overexpression, purification, and role of cysteine 430 | Q71142739 | ||
| Pas de deux or more: the sulfonylurea receptor and K+ channels | Q72155505 | ||
| Covalent inhibitors of P-glycoprotein ATPase activity | Q72671369 | ||
| Protein kinase C-mediated phosphorylation of the human multidrug resistance P-glycoprotein regulates cell volume-activated chloride channels | Q28910230 | ||
| The ATP-binding component of a prokaryotic traffic ATPase is exposed to the periplasmic (external) surface | Q36064136 | ||
| A recombinant peptide model of the first nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator: comparison of wild-type and delta F508 mutant forms | Q36279470 | ||
| Intrinsic anion channel activity of the recombinant first nucleotide binding fold domain of the cystic fibrosis transmembrane regulator protein | Q36846356 | ||
| Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies | Q37660701 | ||
| Nucleotide binding to the hydrophilic C-terminal domain of the transporter associated with antigen processing (TAP). | Q38308202 | ||
| The cystic fibrosis transmembrane conductance regulator. Overexpression, purification, and characterization of wild type and delta F508 mutant forms of the first nucleotide binding fold in fusion with the maltose-binding protein | Q38314343 | ||
| Domain organization of murine mdr1b P-glycoprotein: the cytoplasmic linker region is a potential dimerization domain. | Q38349319 | ||
| Overexpression of integral membrane proteins for structural studies | Q40370871 | ||
| The Cystic Fibrosis Transmembrane Conductance Regulator | Q40486029 | ||
| The nucleotide binding folds of the cystic fibrosis transmembrane conductance regulator are extracellularly accessible | Q41103955 | ||
| Phosphorylation by cAMP-dependent protein kinase causes a conformational change in the R domain of the cystic fibrosis transmembrane conductance regulator | Q41661209 | ||
| Multidrug transporters from bacteria to man: similarities in structure and function | Q41688649 | ||
| Muscarinic stimulation of gallbladder epithelium. III. Antagonism of cAMP-mediated effects | Q42493563 | ||
| Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein | Q42804859 | ||
| Expression and characterization of the NBD1-R domain region of CFTR: evidence for subunit-subunit interactions | Q46698059 | ||
| Overexpression and purification of the carboxyl-terminal nucleotide-binding domain from mouse P-glycoprotein. Strategic location of a tryptophan residue. | Q50769282 | ||
| A recombinant polypeptide model of the second nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator functions as an active ATPase, GTPase and adenylate kinase. | Q53967795 | ||
| Stimulation of CFTR activity by its phosphorylated R domain. | Q54558597 | ||
| Cystic fibrosis transmembrane conductance regulator: the first nucleotide binding fold targets the membrane with retention of its ATP binding function. | Q54567502 | ||
| Expression in Escherichia coli of cytoplasmic portions of the cystic fibrosis transmembrane conductance regulator: apparent bacterial toxicity of peptides containing R-domain sequences. | Q54593967 | ||
| Cloning, overexpression, purification, and characterization of the carboxyl-terminal nucleotide binding domain of P-glycoprotein. | Q54610591 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glutathione | Q116907 |
| multiple drug resistance | Q643839 | ||
| P304 | page(s) | 77-81 | |
| P577 | publication date | 1999-02-01 | |
| P1433 | published in | Biochemical Journal | Q864221 |
| P1476 | title | Expression and purification of the first nucleotide-binding domain and linker region of human multidrug resistance gene product: comparison of fusions to glutathione S-transferase, thioredoxin and maltose-binding protein | |
| P478 | volume | 338 ( Pt 1) |
| Q34228979 | A critical review of the methods for cleavage of fusion proteins with thrombin and factor Xa. |
| Q83451020 | An effective extracellular protein secretion by an ABC transporter system in Escherichia coli: statistical modeling and optimization of cyclodextrin glucanotransferase secretory production |
| Q41941212 | Comparison of SUMO fusion technology with traditional gene fusion systems: enhanced expression and solubility with SUMO. |
| Q33663922 | Expression, purification and structural properties of ABC transporter ABCA4 and its individual domains |
| Q37038082 | Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle |
| Q73089741 | Fusions to maltose-binding protein: control of folding and solubility in protein purification |
| Q41881965 | Mining mammalian genomes for folding competent proteins using Tat-dependent genetic selection in Escherichia coli |
| Q34014094 | Nucleotides and phospholipids compete for binding to the C terminus of KATP channels |
| Q24633871 | Production of therapeutic proteins in algae, analysis of expression of seven human proteins in the chloroplast of Chlamydomonas reinhardtii |
| Q28345106 | Rapid screening for improved solubility of small human proteins produced as fusion proteins in Escherichia coli |
| Q44075217 | S-decyl-glutathione nonspecifically stimulates the ATPase activity of the nucleotide-binding domains of the human multidrug resistance-associated protein, MRP1 (ABCC1). |
| Q36220537 | SUMO fusion technology for difficult-to-express proteins |
| Q33636884 | Self-assembly of virus-like particles of porcine circovirus type 2 capsid protein expressed from Escherichia coli |
| Q37486455 | Several affinity tags commonly used in chromatographic purification |
| Q42565132 | Site-directed mutagenesis and expression of the soluble form of the family IIIa cellulose binding domain from the cellulosomal scaffolding protein of Clostridium cellulovorans |
| Q84872265 | Syntaxin-1A inhibits KATP channels by interacting with specific conserved motifs within sulfonylurea receptor 2A |
| Q44525552 | The N-terminal stem region of bovine and human beta1,4-galactosyltransferase I increases the in vitro folding efficiency of their catalytic domain from inclusion bodies |
| Q43122669 | The NBDs that wouldn't die: A cautionary tale of the use of isolated nucleotide binding domains of ABC transporters. |
| Q44373782 | The nucleotide-binding domains of P-glycoprotein. Functional symmetry in the isolated domain demonstrated by N-ethylmaleimide labelling |
| Q35661122 | The use of Bcl-2 over-expression to stabilize hybridomas specific to the HERG potassium channel |
Search more.